Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies

PrEP and early ART initiation can delay or reduce HIV detectability. Considerations for the implementation of NAT and Ag/Ab tests in PrEP/PEP programs relying on Ab-only RDTs should be balanced according to feasibility and public health impact. While blood transfusion services using Ab-only RDTs for HIV screening should adopt higher sensitivity tests, surveillance and further research are needed to determine the need for novel HIV testing algorithms for those already using NAT and Ag/Ab screening assays.

Authors

Institutions

Publication Details

Journal
International Journal of Infectious Diseases
Published
2024-08-25
DOI
https://doi.org/10.1016/j.ijid.2024.107222
Citations
15
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
5.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies

Jairam R. Lingappa, Steven H Kleinman, Vivian I. Avelino‐Silva, Shelley N. Facente et al.
15 citations
International Journal of Infectious Diseases
HIV/AIDS Research and Interventions
5.84
article

Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies

Jairam R. Lingappa, Steven H Kleinman, Vivian I. Avelino‐Silva, Shelley N. Facente, Robert M. Grant, David J. Wright, Sandhya Vasan, Siriwat Akapirat, Eduard Grebe, Brian Custer, Mark de Souza, Philip J. Norris, Nittaya Phanuphak, Carlo Sacdalan, Mars Stone, Megha Mehrotra, Michael Paul Busch, Clara Di Germanio, Patricia A. Defechereux, Michael Schmidt, Xutao Deng, Sonia Bakkour, Ashtyn L Conway
article en
15 citations

Abstract

PrEP and early ART initiation can delay or reduce HIV detectability. Considerations for the implementation of NAT and Ag/Ab tests in PrEP/PEP programs relying on Ab-only RDTs should be balanced according to feasibility and public health impact. While blood transfusion services using Ab-only RDTs for HIV screening should adopt higher sensitivity tests, surveillance and further research are needed to determine the need for novel HIV testing algorithms for those already using NAT and Ag/Ab screening assays.

International Journal of Infectious DiseasesVol. 148
Henry M. Jackson Foundation (US), Gladstone Institutes (US), Westat (United States) (US), University of British Columbia (CA), Chulalongkorn University (TH), University of California, San Francisco (US), University of Washington (US), Bloodworks Northwest (US), German Red Cross (DE), Pacific Research Institute (US), Armed Forces Research Institute of Medical Science (TH), HIV Netherlands Australia Thailand Research Collaboration (TH), Bangkok University (TH)
U.S. Department of Defense, Henry M. Jackson Foundation, Gilead Sciences, ViiV Healthcare, Grifols, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 3%
HIV/AIDS Research and Interventions
5.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.